Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Change in Accured Expenses (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Change in Accured Expenses for 3 consecutive years, with -$37.9 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 1846.61% to -$37.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.0 million through Sep 2025, up 259.78% year-over-year, with the annual reading at -$1.4 million for FY2023, 163.28% down from the prior year.
  • Change in Accured Expenses hit -$37.9 million in Q4 2025 for Immunocore Holdings, down from $37.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $37.9 million in Q3 2025 to a low of -$44.1 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged -$112750.0 across 3 years, with a median of $418500.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: soared 4331.57% in 2024 and later crashed 1846.61% in 2025.
  • Year by year, Change in Accured Expenses stood at -$24.5 million in 2023, then skyrocketed by 92.04% to -$1.9 million in 2024, then plummeted by 1846.61% to -$37.9 million in 2025.
  • Business Quant data shows Change in Accured Expenses for IMCR at -$37.9 million in Q4 2025, $37.9 million in Q3 2025, and $10.9 million in Q2 2025.